Literature DB >> 5014618

The metabolism of proinsulin and insulin by the liver.

A H Rubenstein, L A Pottenger, M Mako, G S Getz, D F Steiner.   

Abstract

The removal of bovine proinsulin by the isolated perfused rat liver has been studied and the results compared with the removal of insulin. At high concentrations of insulin (> 180 ng/ml) the removal process was saturated and the t(1/2) varied between 35 and 56 min. With low initial insulin levels the disappearance followed first-order kinetics, the mean regression coefficient being - 0.022, t(1/2) 13.8 min, and the hepatic extraction 4.0 ml/min. The results with proinsulin were in striking contrast to these findings. At both high and low concentrations the hepatic removal of proinsulin was considerably slower, averaging 10-15 times less than that of insulin. Specific immunoassay techniques and gel filtration of samples taken from perfusions to which both labeled and unlabeled proinsulin had been added did not show conversion to either insulin or the C-peptide. Bovine and rat (131)I-labeled proinsulins were degraded more slowly than bovine insulin-(131)I by bovine and rat liver homogenates. Both proinsulin and insulin inhibited the degradation of insulin-(131)I, equimolar quantities of proinsulin being 2-5 times less effective than insulin. These results indicate significant differences in the capacity of the liver to remove and degrade insulin and proinsulin. The low hepatic extraction of proinsulin may account for its prolonged half-life in vivo and contribute to its relatively high plasma concentration in the fasting state. Furthermore this finding will have to be taken into account in the interpretation of changes in the proinsulin:insulin ratios in peripheral blood in a variety of metabolich situations.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5014618      PMCID: PMC302205          DOI: 10.1172/JCI106886

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  FATE OF RAT INSULIN IN RAT-LIVER PERFUSION STUDIED BY ADIPOSE-TISSUE ASSAY.

Authors:  H BUERGI; K SCHWARZ; K KOPETZ; E R FROESCH
Journal:  Lancet       Date:  1963-08-17       Impact factor: 79.321

2.  Studies on the specificity of an insulin-inactivating system of the liver.

Authors:  H H TOMIZAWA; R H WILLIAMS
Journal:  J Biol Chem       Date:  1955-12       Impact factor: 5.157

3.  Insulin biosynthesis in the rat: demonstration of two proinsulins.

Authors:  J L Clark; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1969-01       Impact factor: 11.205

4.  Glucagon clearance by the isolated perfused rat liver.

Authors:  K D Buchanan; S S Solomon; J E Vance; H P Porter; R H Williams
Journal:  Proc Soc Exp Biol Med       Date:  1968-06

5.  Hepatic effect of sulfonylureas.

Authors:  A Marshall; R L Gingerich; P H Wright
Journal:  Metabolism       Date:  1970-12       Impact factor: 8.694

6.  Effects of stimulation of the vagus nerve on insulin secretion.

Authors:  A Kaneto; K Kosaka; K Nakao
Journal:  Endocrinology       Date:  1967-03       Impact factor: 4.736

7.  Human serum proinsulin.

Authors:  F Melani; A H Rubenstein; D F Steiner
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

8.  Plasma protein catabolism by the perfused rat liver. The effect of alteration of albumin concentration and dietary protein depletion.

Authors:  R Hoffenberg; A H Gordon; E G Black; L N Louis
Journal:  Biochem J       Date:  1970-07       Impact factor: 3.857

9.  Insulin delivery rate into plasma in normal and diabetic subjects.

Authors:  M P Stern; J W Farquhar; A Silvers; G M Reaven
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

10.  Proinsulin secretion by a pancreatic beta-cell adenoma. Proinsulin and C-peptide secretion.

Authors:  F Melani; W G Ryan; A H Rubenstein; D F Steiner
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

View more
  38 in total

1.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  Exocrine and endocrine functional reserve in the course of chronic pancreatitis as studied by maximal stimulation tests.

Authors:  G Cavallini; P Bovo; M Zamboni; O Bosello; M Filippini; A Riela; G Brocco; L Rossi; C Pelle; A Chiavenato
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

3.  A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin.

Authors:  N Barzilai; P H Groop; L Groop; R A DeFronzo
Journal:  Acta Diabetol       Date:  1995-12       Impact factor: 4.280

4.  The role of the liver in glucagon metabolism.

Authors:  J B Jaspan; A H Huen; C G Morley; A R Moossa; A H Rubenstein
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

5.  Specific and direct radioimmunoassay for human proinsulin in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

6.  Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance.

Authors:  M C Amato; R Vesco; E Vigneri; A Ciresi; C Giordano
Journal:  J Endocrinol Invest       Date:  2015-08-21       Impact factor: 4.256

7.  C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

Authors:  K S Polonsky; W Pugh; J B Jaspan; D M Cohen; T Karrison; H S Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

8.  Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Québec Family Study.

Authors:  L Bouchard; S J Weisnagel; J C Engert; T J Hudson; C Bouchard; M C Vohl; L Pérusse
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

9.  Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.

Authors:  R Ebert; W Creutzfeldt
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

10.  The measurement and validation of the nonsteady-state rates of C-peptide appearance in the dog.

Authors:  T Morishima; S Pye; K Polonsky; J Radziuk
Journal:  Diabetologia       Date:  1986-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.